|
351
|
|
|
Proenkephalin |
PE, PENK-A |
|
|
352
|
|
|
Peptidase D |
PROLIDASE |
Androgenetic alopecia, Cataract, Skin ulcer, Prolidase deficiency, Diabetes mellitus type 2, Gestational diabetes, Hepatomegaly, Hypertension, Metabolic syndrome, Psoriasis, Respiratory system infectious disease, Schizophrenia, Splenomegaly, Diabetes mellitus, type 2, Venous thromboembolism |
|
353
|
|
|
Period circadian regulator 1 |
PER, RIGUI, hPER |
|
|
354
|
|
|
Period circadian regulator 2 |
FASPS, FASPS1 |
|
|
355
|
|
|
Period circadian regulator 3 |
FASPS3, GIG13 |
Advanced sleep phase syndrome, Bipolar disorder, Breast neoplasm, Crohn disease, Bipolar depression, Major depressive disorder, Advanced sleep-phase syndrome, Homocystinuria with megaloblastic anemia, Inflammatory bowel disease, Osteoarthritis, Seasonal affective disorder, Substance abuse |
|
356
|
|
|
Proline and glutamate rich with coiled coil 1 |
DIAR11, ICR, gs104 |
|
|
357
|
|
|
PPARGC1 and ESRR induced regulator, muscle 1 |
C1orf170 |
|
|
358
|
|
|
P53 apoptosis effector related to PMP22 |
EKVP7, KCP1, KRTCAP1, OLMS2, PIGPC1, THW, dJ496H19.1 |
|
|
359
|
|
|
Pescadillo ribosomal biogenesis factor 1 |
NOP7, PES |
|
|
360
|
|
|
PET100 cytochrome c oxidase chaperone |
C19orf79, MC4DN12 |
|